To compare two group treatment programmes for obese outpatients. Both programmes included behaviour modification, nutrition counselling, very-low-calorie diet (VLCD) and a continuous measuring of metabolic and anthropometrical status, but they differed regarding the treatment intensiveness. The main aim was to study whether intensive treatment gives a larger weight reduction compared with less intensive treatment and what level of input from health care personnel is needed to reach adequate treatment results. DESIGN: A 2-y randomised clinical trial. SUBJECTS: A total of 43 obese subjects aged 24-60 y, BMI 35 kg/m 2 (29-48). INTERVENTION: Two programmes were used. Both were based on group therapy and were supervised by a dietitian and a psychologist. Group 1 received a continuous intensive treatment with planned group meetings every fortnight during the first year and six group meetings the second year. Group 2 had planned group meetings every third month. Anthropometrical and metabolic data were measured every third month in both groups. The VLCD periods were the same. RESULTS: There was no evidence that a more intensive treatment promotes a larger weight reduction. Weight reduction after 1 y: group 1, À7.6 (70.97) kg, BMI À2.6 (70.3) kg/m 2 ; group 2, À6.4 (71.16) kg, BMI À2.2 (70.4) kg/m 2 . Weight reduction after 2 y: group 1, À6.8 (71.4) kg, BMI À2.4 (70.3) kg/m 2 ; group 2, À8.6 (71.6) kg, BMI À3.0 (70.3) kg/m 2 . The dropout rate was 26%. CONCLUSION: There were no significant differences in weight reduction, compliance or dropout rate between the groups and there was no evidence that a more intensive treatment promotes a larger weight reduction. This observation is of value when setting up treatment programmes. To measure the metabolic and anthropometrical status during the treatment and to give continuous feedback to the subjects seem to be important factors for compliance. Both treatment programmes gave highly significant weight reductions in the range of 5-10%, which has been referred to as a realistic goal for the treatment of obese patients.
Introduction
Overweight and obesity are well-known risk factors for increased morbidity and mortality as well as for impaired quality of life. Personal eating behaviours, physical activity and other lifestyle habits are in many cases unconscious behaviour. The purpose of the treatment is to help persons become conscious of their own behaviour and to give them the support that is needed to take long-term control over their own lives and change their lifestyle. Behavioural change is obtained through practising new behaviours to increase the likelihood of treatment success. Emphasis is on the individual interplay with environment. To modify or change daily behaviour is a significant intervention in human and in family life.
1,2 A programme to assist persons to become conscious of their behaviour and start a process of behaviour change includes education, motivation, activating of the person and presence in situations where extra support is needed. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Awareness and the identification are starting points and first steps in identifying the habits that are easiest to change. There is an urgent need for randomised long-term studies of treatment of obesity. 3, 4 This treatment programme focused on behaviour changes, including food habits, alcohol consumption, physical activity, risk situations that lead to a relapse, circumstances that might lead to uncontrolled eating, hunger and craving, and satisfaction-happiness.
The main aim of this study was to explore whether intensive treatment produced greater weight loss and weight stability compared with less intensive treatment and to define a reasonable level of input from health care personnel to reach adequate treatment results. The objective was to compare two group treatment programmes for obese outpatients. Both programmes included behaviour modification, nutrition counselling, very-low-calorie diet (VLCD) and continuous measuring of metabolic and anthropometrical status.
Methods

Subjects
The patients were referred to the clinic due to obesity, with complications and diagnoses like diabetes mellitus type II, hypertension, dyslipoproteinaemia, polycystic ovary disease and sleep apnoea disorder. BMI was calculated as body weight in kilograms without shoes and with light clothing divided by height (in metres) squared. Height was rounded to 0.5 cm. Body weight was measured on a digital scale with an accuracy of 0.1 kg. Two trained observers for each subject performed the measurement of weight and height. 11 The laboratory tests were performed according to clinical routine. Blood glucose concentrations were determined by the glucose oxidase method. 12 Serum insulin assays were performed by the Phadebas test (Pharmacia, Uppsala, Sweden). 12 The blood pressure was measured in the right arm with a sphygmomanometer. The cuff size was 15.45 cm depending on the arm circumference. The recordings were made to the nearest 2 mmHg twice after 10 min supine rest, and the mean of the two measurements was used in the analyses. The patients met a physician for an initial medical examination and discussion of the treatment offered. Before participating in the treatment, all patients met individually with the dietitian. The patients were then invited to an information meeting where they had an opportunity to decide if they were interested in participating in the treatment. Consent from the subjects was finally obtained at this meeting. A contract with obligations between the clinic and the patient was drawn up, specifying guiding principles that the patient as well as the health care personnel should follow in an attempt to increase the attendance. The meetings were supervised by the dietitian and the psychologist. Regarding the patients' background data, clinical characteristics and their desire and belief regarding the success of the weight reduction programme were collected in questionnaires.
Statistical methods
Data are presented as mean and standard deviation (s.d.) or standard error of mean (s.e.m.) or minimum and maximum values by treatment group or by gender or by high or low attendance. In the case of skewed distributions of variables (which was defined as Wo0.95 in Shapiro-Wilk's test), a logarithmic transformation was performed. The statistical analyses are based on treatment effects (change from baseline) to 3, 6, 12 and 24 months within and between groups. Analysis methods are thus paired and unpaired t-tests. All tests are two-tailed, and Po0.05 was considered statistically significant. For weight reduction and attendance, results are also presented as 95% confidence intervals.
Study design
Principal design and randomisation In total, 43 subjects were included in the study. After medical examination, the subjects were randomised into two groups according to gender, age and BMI: an intensively treated group (group 1) and a less intensively treated group (group 2.) Table 1 describes the baseline characteristics of the study groups. Behavioural modification in treatment of obesity I Melin et al
Subject characteristics
All 43 patients had been treated before for their obesity, and had on average attended 2-3 programmes either in hospitals or in primary health care. Half of the patients had attended Weight Watchers several times. These treatments had resulted in initial weight reduction soon followed by weight gain. The patients were now interested in participating again because they were worried about their health and felt uncomfortable being obese. Table 2 describes the subjects' personal characteristics and reported causes of weight gain. The two groups were similar with regard to anthropometric and metabolic characteristics. One woman in group 1 had experienced gestational diabetes and three subjects in group 2 had diabetes mellitus. None was on insulin treatment.
Treatment differences
Two programmes were used based on group therapy. Figure 1 shows the study design. The subjects in group 1 received continuous intensive treatment with planned group meetings every fortnight during the first year and six meetings during the second year. They had more intensive care than group 2, including the possibility to repeat the self-monitoring and obtain more information and education in nutrition, food habits and strategies to control the eating behaviour. Group 2 met more seldom, with planned group meetings every third month. They had less contact with the supervisors, fewer repetitions with self-monitoring and less possibilities of nutrition counselling.
Treatment similarities
Anthropometrical and metabolic data were measured every third month in both groups. The VLCD periods were the same. During these periods, the subjects were on sick leave, in order to be able to take part in all the planned activities: education in dietetics, self-monitoring and step-by-step exercising to change their daily behaviour.
Treatment program 4 days food record by household measures
Before the study began, all subjects registered their food intake as a basis for dietary advice. The patient's average fat intake per day before the study was 36 E% (74 g). The intake of carbohydrate per day was 45 E% (200 g) and consisted mainly of simple carbohydrates like sucrose. The fibre intake was only 11 g/day, due to a low consumption of fruit and fibre-rich vegetables and coarse rye bread. The patient's choice of vegetables was lettuce, cucumber and tomato. The average intake of protein per day was 17 E% (72 g), mainly reflecting consumption of cheese and milk products. Baseline data for the 4 days food record by household measures for all the subjects are given in Table 3 .
VLCD period
During the VLCD periods, both groups received the same treatment regimen, including group meetings twice a week Behavioural modification in treatment of obesity I Melin et al supervised by a dietitian and a psychologist. The meetings were devoted to nutrition education and treatment towards behaviour modification. The VLCD periods were 25 days. The subjects were instructed to decrease their energy intake successively during 3 days from 800 kcal down to a level of approximately 200 kcal/day, and to keep this intake during the following 19 days. The energy intake was then progressively increased again to 800 kcal/day during the last 3 days of the VLCD period. The subjects were instructed to drink liquids every 2 h. The liquid prescribed consisted of water, herbal tea, different kinds of fruit and vegetable juice. The VLCD has been used in earlier programmes at the clinic in an attempt to achieve a rapid and significant reduction of body weight to motivate future weight reduction, improve metabolic control and as a tool to change eating behaviour.
13-15
Dietary treatment After the VLCD period, ordinary food was gradually introduced. All the subjects were prescribed an individualised hypocaloric diet aiming at an energy deficit of approximately 600 kcal/day. Food recommendations were based on Nordic Nutritional Guidelines. 16 Education in nutrition and food habits was given, and self-monitoring and strategies to control eating behaviour were discussed to support the subjects to a step-by-step move from precontemplation and contemplation to action and maintenance.
Health education
All the subjects were informed about the risk factors of being obese, and about the aspects of the metabolic syndrome and the function of the body. The connections between food, health and disease, metabolism, appetite control and medical risk factors as well as basic facts about energy and the ABCs of nutrition were also discussed. Meetings were organised with the subject's family members to inform about the treatment programmes in an effort to activate the whole family to change their lifestyle, eating behaviour and to increase their physical activities.
Behaviour treatment.. Self-monitoring was used as a tool to follow the behaviour change process, through evaluation of progress, and identification of personal and environmental influences that regulate eating and physical activity. The treatment focused on eating behaviour, hunger and craving, relapse situations, physical activities and satisfactionhappiness. A more precise description is presented below.
Eating behaviour. The self-monitoring on what, when and how they eat was performed two times during the first year: before starting the programme to register food habits and the possibilities of making changes, and at the end of the treatment to describe the changes brought about and stress on how to make the new habits permanent and how to focus on the next step needed in the process of changing food habits.
Hunger and craving. The patients registered their feelings of hunger and craving during 4 days before, during and after the VLCD period and every third month during the treatment. 17 At the end of the treatment, the patients summarised changes in hunger and craving and their effect and connection with meal planning and weight reduction. The self-monitoring was used to distinguish the feeling of hunger from the craving, and enable the participants to manage feelings and identify the connection between the feelings and advantage of meal planning.
Relapse situations. Earlier relapse situations were analysed and ranked in order of difficulty. Plans were made on how to avoid or handle these high-risk situations by changing the behaviour chain leading to overeating.
Monitoring of physical activities. The self-monitoring was used to motivate the patient to be more physically active, through monitoring the habitual pattern of mobility and the possibility and space to be more physically active. Possibilities to increase physical activity or exercise were discussed and individual plans were made due to these discussions. The subjects monitored their physical activity over 7 days.
8,18
Satisfaction-happiness. Situations that give satisfaction and joy in a subject's life were identified. The patient makes plans to increase these feelings.
Pedagogic structure of the group meetings The supervisor made a short introduction and checked attendance, the subjects' weight, and whether the selfmonitoring tasks had been performed. The subjects used 5 Behavioural modification in treatment of obesity I Melin et al min in silence to prepare their oral presentation of the selfmonitoring: Table' procedure was applied. Thus, each member of the group relates his/her experiences, one at a time. Thoughts and experiences related to homework were shared within the group. * Conclusion and discussion of the subjects' individual selfmonitoring were based on the experiences during the 'Round Table' . The supervisor summarised and commented on the discussion, and gave feedback regarding earlier discussions and experiences on a group and at individual level. * Information about the theme of the next meeting and instruction of the next self-monitoring exercise was given.
Results
Attendance at the group meetings Attendance at the group meetings was, in both groups, on average 60%. The dropout rate was 26% and a consort of the patient flow is shown in Table 4 . All subjects completed the first VLCD periods. In VLCD period number two, all the subjects in group 1, who remained after 1 y, participated. In group 2, 13 subjects participated. Five could not participate due to working conditions. The VLCD periods were well tolerated and no adverse changes in laboratory parameters were seen.
Attendance and weight reduction
High attendance in the programmes was defined as twothirds (over 60%) compliance at all the treatment interventions. Participation in examinations of anthropometric and metabolic measures and attendance at the group meetings were, in this study, associated with weight reduction at 12 and 24 months; however, the association was not significant. Attendances at the metabolic and anthropometrical examination were on average 75% in both groups. The results are shown in Table 5 .
After 2 y A total of 24 subjects (56%) reported before the study that they believed that there was no risk or a small risk of being back to initial weight after 2 y. A total of 19 subjects (44%) thought that there was a rather large risk or a very large risk that this might happen. After 2 y, 28 subjects (65%) had reached weight stability with an average weight reduction of 8.5 (0.2-37.9) kg. In all, 12 subjects (28%) lost À25oxoÀ10%, eight subjects (18.6) lost À10oxoÀ5% and eight subjects (18.6) lost À5oxo0%. Four women (9.3%) had gained weight 0oxo8%. A total of 11 subjects (26%) dropped out during the treatment programme (Table 6 ). (Table 7) . Table 8 shows changes in metabolic risk factors in relation to weight reduction. After 2 y, significant associations were found between weight reduction and changes in systolic blood pressure and diastolic blood pressure in group 1. Significant changes in S-insulin levels were found in both groups. There were no significant differences between the groups except for diastolic blood pressure. There were only minor/no significant changes after 2 y regarding other metabolic variables (serum lipids, liver transaminases, plasma urate). High attendance in the programmes is defined as two-thirds (over 60%) compliance at all the treatment interventions. Data are mean and s.e.m. There were no significant differences between the attendance groups. a Confidence interval for difference between the two groups regarding changes from baseline. Behavioural modification in treatment of obesity I Melin et al
Weight reduction
Risk factors
Dropouts
Most of the dropouts occurred during the first year, after summer and after the Christmas holidays. Reasons for dropout in both groups were health problems, lack of time, long way to travel, bothersome behaviour and not wanting to continue. The results are shown in Table 9 .
Discussion
This study of obese outpatients illustrates a typical scenario in primary health care, where the possibility to create homogeneous groups of participants is limited. The subject's age, weight and metabolic status varied within the group, from young healthy obese to middle-aged obese subjects, Po0.001 compared with baseline, differences within the groups. There were no significant differences between the groups. a Confidence interval for difference between the two groups regarding changes from baseline. Po0.001 compared with baseline. There were no significant differences between the groups except from diastolic blood pressure at 24 months, * Po0.05. Behavioural modification in treatment of obesity I Melin et al some of them with diagnoses as diabetes mellitus type II, hypertension, dyslipoproteinaemia, polycystic ovary disease and sleep apnoea disorder.
The main aim of this study was to examine whether intensive treatment gives a larger weight reduction than less intensive treatment and what level of input from health care personnel is needed to reach adequate treatment results. In spite of the difference in treatment between groups 1 and 2, including intensity of behaviour modification and nutrition counselling, this study shows no significant difference between the two groups in weight reduction. Attendance at the group meetings was in general over 60% in both groups. High attendance at all the interventions was in this study associated with a larger weight reduction, although the association was not significant (Table 5 ). In group 1, a positive association was seen between high attendance and high weight reduction. In this group, the patients had the opportunity to meet with F and be treated continuously by F health care personnel during 2 y. Findings by MattfeldtBeman et al 19 showed that attendance at intervention sessions and continued adherence to programme components tend to relate to long-term success. This is consistent with the findings of others. 7, 20 Multifaceted programmes comprising continued professional contact, skills training, social support and exercise could enhance the long-term maintenance of weight loss. In group 2, where the numbers of meetings were limited, we did not see the same relation between attendance and weight reduction. The subjects were given continuous feedback on their metabolic status during the treatment, which was highly appreciated by the subjects. This is one way to communicate, to involve the subjects in the treatment, and to make them more interested in their own health and in taking control over the situation. It has been argued that to improve results in short-term treatment, long-term treatment and maintenance programmes, the patient should be informed and prepared for the interaction of biological, physiological and psychological effects and processes in the body. 7, 21 After 2 y, 28 of the 43 subjects (65%) had reduced their body weight. These 28 subjects are successful maintainers and their chances to keep their new weight in the long term are greatly increased. 22 Foster et al 23 stress that it is important to give information and to discuss realistic goals for weight reduction with the patients before they enter a treatment programme to avoid disappointment that could lead to relapse. A total of 20 subjects (47% of all included) had reduced their body weight 5-10% or more after 2 y. A 5-10% weight reduction has been suggested as a realistic goal for the treatment of obese patients, [24] [25] [26] and has well documented beneficial effects on established cardiovascular risk factors. 27, 28 There were no significant differences between the groups except for diastolic blood pressure. There were significant changes in systolic and diastolic blood pressure in group 1 after 2 y, but these changes were surprisingly not seen in group 2 in spite of similar weight reduction.
There were also significant changes in S-insulin levels in both groups. A weight reduction of 5-10% and reduced insulin levels indicated that lifestyle changes including changed food habits and increased physical activity had been obtained. This magnitude of weight reduction might prevent or delay and reduce the incidence of diabetes type II in predisposed individuals. 25, 26 Treatment with VLCD and an active follow-up treatment seem to relate to long-term weight-maintenance success 6, [29] [30] [31] [32] where rapid and major weight reduction was suggested to be an important motivation factor. The VLCD used in this study have successfully been used in earlier programmes at the clinic, in an attempt to achieve a fast and major reduction of the body weight, as a motivation factor, to improve metabolic control and as a tool to change eating behaviour. [13] [14] [15] VLCD is defined as a diet of 3350 kJ (800 kcal/day) or less. 33 The low energy level of VLCD that we used is nowadays generally abandoned as there is little evidence that an intake of less than 800 kcal/day will further improve the results of the treatment.
At the beginning of the study, the subjects registered their habitual energy intake F on average 1785 kcal ( Table 3 ). The actual energy intake was probably higher than that reported. Obese subjects tend to under-report their energy intake to a higher degree than people with normal weight. 34 To achieve more reliable data, the food registrations should be repeated several times during a prolonged period of time.
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The dropout rate during 2 y was 26%. There was no significant difference in dropout rate between the groups. The result is in accordance with some previous trials using academic treatment programmes. 36 Better screening methods, motivation analysis and treatment procedures might improve this figure. This study shows that long holidays, such as at Christmas and during summer time, were critical times for dropout. The health care personnel should be aware of this and the treatment programme designed to meet this problem by preparing and activating the subjects before and during the holidays. The structure of the treatment programmes combining behaviour modification, nutrition counselling and VLCD periods, and repeatedly monitoring the metabolic and anthropometrical status proved to be an effective tool in group treatment and facilitated the communication between the patient and the supervisor. The subjects had during treatment an opportunity to meet with health personnel and discuss and share their experiences, concrete situations and problems on both an individual and group level. The selfmonitoring gave an interesting basis for discussion and gave the individual patient motivation to take relevant steps towards behaviour change. 8, 18 Dietary intervention is the basis for all treatment of obesity in both children and adults. Behavioural therapy, individually or in groups, can help to promote dietary changes and increase physical activity.
1,2
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Future perspectives
To improve weight reduction and lifestyle changes, screening, motivation analysis and a long follow-up period are needed. 1, 5 A time period of 10 y would be desirable. The patient's readiness to change health behaviour is an important factor to take into consideration. Brownell et al 6 point out the importance of screening, prior to the weight reduction programme to help match individuals and to focus professionally on those most likely to succeed. Greene et al 37 argue that stage of change is a temporal dimension of motivational readiness to change health behaviour. 37 Kristal et al 9 stress that the stages of change construct can be helpful in designing, delivering and evaluating interventions to help people adopt more healthful diets. 9 Further research should be directed towards structural treatment programme, screening methods and motivation analysis, easy to use in the clinic. Finally, it is important to educate health care personnel in the treatment of obesity and in how to use screening methods and investigate the patient's motivational level.
3,38,39
Conclusion
This study has not directly evaluated changes in food habits, physical activities and lifestyle. Focus has been on evaluating two programmes, using more or less intensive treatment, trying to optimise the input of work from health care personnel to reach adequate treatment results. There was no significant difference in weight reduction, compliance or dropout rate between the groups. Thus, there was no evidence that a more intensive treatment promotes a larger weight reduction. This observation is important from an economical point of view when setting up treatment programmes. However, there seemed to be a positive association between high attendance at all interventions and weight reductions. To measure the metabolic and anthropometrical status during the treatment and to give continuous feedback to the subjects seem to be important factors.
